Is Monopar Therapeutics Inc. (MNPR) a Buy, Sell, or Hold?
Monopar Therapeutics Inc.
NASDAQ:MNPR
$99.79 USD
-$3.54 (-3.43%)
- Volume
- 498.25K
- Average Volume
- 172.64K
- Market Capitalization
- $668.5M
- P/E Ratio
- -48.21
- Dividend Yield
- 0.00%
- Price Target
- $105.00
- Year High
- $112.57
- Year Low
- $29.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $56.04
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
28
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
28
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 754.79K
MNPR Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
MNPR Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Vu Quan Anh | officer: Chief Financial Officer | 2026-06-30 | M-Exempt | 0 | 2026-07-02 |
| Vu Quan Anh | officer: Chief Financial Officer | 2026-06-30 | M-Exempt | 0 | 2026-07-02 |
| Vu Quan Anh | officer: Chief Financial Officer | 2026-06-30 | F-InKind | 92.59 | 2026-07-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2026-06-30 | M-Exempt | 0 | 2026-07-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2026-06-30 | F-InKind | 92.59 | 2026-07-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2026-06-30 | M-Exempt | 0 | 2026-07-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2026-06-30 | M-Exempt | 0 | 2026-07-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2026-06-30 | F-InKind | 92.59 | 2026-07-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2026-06-30 | M-Exempt | 0 | 2026-07-02 |
| Sweeny Nicole | director | 2026-06-26 | A-Award | 87.68 | 2026-06-30 |
| Sweeny Nicole | director: | 2026-06-22 | 0 | 2026-06-30 | |
| Robinson Chandler | director, officer: Chief Executive Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2026-03-31 | F-InKind | 54.79 | 2026-04-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2026-03-31 | F-InKind | 54.79 | 2026-04-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Rodriguez Susan | officer: CCSO | 2026-03-02 | A-Award | 53.47 | 2026-03-04 |
| Rodriguez Susan | officer | 2026-03-02 | 0 | 2026-03-04 | |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-01-28 | J-Other | 0 | 2026-01-30 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-12-31 | F-InKind | 65.3 | 2026-01-05 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-12-31 | F-InKind | 65.3 | 2026-01-05 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| RIOUX PATRICE | other: Acting Chief Medical Officer | 2026-01-01 | A-Award | 65.3 | 2026-01-05 |
| Vu Quan Anh | officer: Chief Financial Officer | 2025-12-26 | P-Purchase | 69.95 | 2025-12-29 |
| KLAUSNER ARTHUR J | director | 2025-12-18 | S-Sale | 67.06 | 2025-12-19 |
| KLAUSNER ARTHUR J | director | 2025-12-18 | S-Sale | 68.09 | 2025-12-19 |
| Hendricks Diane | 10 percent owner | 2025-12-16 | J-Other | 0 | 2025-12-17 |
| KLAUSNER ARTHUR J | director | 2025-12-16 | J-Other | 0 | 2025-12-17 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-12-02 | A-Award | 0 | 2025-12-08 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-12-02 | A-Award | 75.94 | 2025-12-08 |
| STARR CHRISTOPHER M | director | 2025-12-02 | A-Award | 75.94 | 2025-12-08 |
| KLAUSNER ARTHUR J | director | 2025-12-02 | A-Award | 75.94 | 2025-12-08 |
| Anderson Raymond | director | 2025-12-02 | A-Award | 75.94 | 2025-12-08 |
| Talukdar Lavina | director | 2025-12-02 | A-Award | 75.94 | 2025-12-08 |
| Tsuchimoto Kim R | director | 2025-12-02 | A-Award | 75.94 | 2025-12-08 |
| Vu Quan Anh | officer: Chief Financial Officer | 2025-12-02 | A-Award | 0 | 2025-12-08 |
| Vu Quan Anh | officer: Chief Financial Officer | 2025-12-02 | A-Award | 75.94 | 2025-12-08 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-12-02 | A-Award | 0 | 2025-12-08 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-12-02 | A-Award | 75.94 | 2025-12-08 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-09-30 | M-Exempt | 0 | 2025-10-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-09-30 | F-InKind | 81.67 | 2025-10-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-09-30 | M-Exempt | 0 | 2025-10-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-09-30 | M-Exempt | 0 | 2025-10-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-09-30 | F-InKind | 81.67 | 2025-10-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-09-30 | M-Exempt | 0 | 2025-10-02 |
| Tactic Pharma LLC | 10 percent owner | 2025-09-24 | S-Sale | 63.6098 | 2025-09-26 |
| Tsuchimoto Kim R | director | 2025-07-14 | X-InTheMoney | 0.005 | 2025-07-16 |
| Tsuchimoto Kim R | director | 2025-07-14 | S-Sale | 40.0012 | 2025-07-16 |
| Tsuchimoto Kim R | director | 2025-07-14 | X-InTheMoney | 0.005 | 2025-07-16 |
| STARR CHRISTOPHER M | director | 2025-07-14 | X-InTheMoney | 0.005 | 2025-07-16 |
| STARR CHRISTOPHER M | director | 2025-07-14 | S-Sale | 40.0012 | 2025-07-16 |
| STARR CHRISTOPHER M | director | 2025-07-14 | X-InTheMoney | 0.005 | 2025-07-16 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-07-14 | X-InTheMoney | 0.005 | 2025-07-16 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-07-14 | S-Sale | 40.0012 | 2025-07-16 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-07-14 | X-InTheMoney | 0.005 | 2025-07-16 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-06-30 | M-Exempt | 0 | 2025-07-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-06-30 | M-Exempt | 0 | 2025-07-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-06-30 | F-InKind | 35.78 | 2025-07-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-06-30 | M-Exempt | 0 | 2025-07-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-06-30 | F-InKind | 35.78 | 2025-07-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-06-30 | M-Exempt | 0 | 2025-07-02 |
| Tactic Pharma LLC | 10 percent owner | 2025-04-02 | S-Sale | 35 | 2025-04-04 |
| Cittadine Andrew | officer: Chief Operating Officer | 2024-03-31 | M-Exempt | 0 | 2025-04-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-03-31 | M-Exempt | 0 | 2025-04-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-03-31 | F-InKind | 36.41 | 2025-04-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-03-31 | M-Exempt | 0 | 2025-04-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-03-31 | M-Exempt | 0 | 2025-04-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-03-31 | F-InKind | 36.41 | 2025-04-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-03-04 | A-Award | 0 | 2025-03-07 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-03-04 | M-Exempt | 0 | 2025-03-07 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-03-04 | A-Award | 31.7 | 2025-03-07 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-03-04 | M-Exempt | 0 | 2025-03-07 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2025-03-04 | F-InKind | 31.7 | 2025-03-07 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-03-04 | A-Award | 0 | 2025-03-07 |
| Cittadine Andrew | officer: Chief Operating Officer | 2025-03-04 | A-Award | 31.7 | 2025-03-07 |
| STARR CHRISTOPHER M | director | 2025-03-04 | A-Award | 31.7 | 2025-03-07 |
| KLAUSNER ARTHUR J | director | 2025-03-04 | A-Award | 31.7 | 2025-03-07 |
| Anderson Raymond | director | 2025-03-04 | A-Award | 31.7 | 2025-03-07 |
| Talukdar Lavina | director | 2025-03-04 | A-Award | 31.7 | 2025-03-07 |
| Tsuchimoto Kim R | director | 2025-03-04 | A-Award | 31.7 | 2025-03-07 |
| Talukdar Lavina | director | 2025-02-21 | 0 | 2025-03-06 | |
| Vu Quan Anh | officer: Chief Financial Officer | 2025-03-03 | A-Award | 30.93 | 2025-03-05 |
| Vu Quan Anh | officer | 2025-03-03 | 0 | 2025-03-05 | |
| RIOUX PATRICE | other: Acting Chief Medical Officer | 2025-01-01 | A-Award | 22 | 2025-01-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2024-12-31 | M-Exempt | 0 | 2025-01-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2024-12-31 | F-InKind | 22 | 2025-01-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2024-12-31 | M-Exempt | 0 | 2025-01-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2024-12-31 | M-Exempt | 0 | 2025-01-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2024-12-31 | F-InKind | 22 | 2025-01-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2024-12-31 | M-Exempt | 0 | 2025-01-02 |
| TacticGem LLC | 10 percent owner | 2024-12-09 | J-Other | 0 | 2024-12-17 |
| Radhakrishnan Karthik | officer: Chief Financial Officer | 2024-10-28 | P-Purchase | 16.25 | 2024-10-30 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2024-09-30 | M-Exempt | 0 | 2024-10-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2024-09-30 | F-InKind | 6.74 | 2024-10-02 |
| Robinson Chandler | director, officer: Chief Executive Officer | 2024-09-30 | M-Exempt | 0 | 2024-10-02 |
| Cittadine Andrew | officer: Chief Operating Officer | 2024-09-30 | M-Exempt | 0 | 2024-10-02 |